IL2RG and leukemia: Although under dispute, the combinatorial effect of the IL2RG transgene in the development of the lymphoproliferative disease in the X-SCID trial has been discussed [132,133] and recent work from Copeland and colleagues provides supportive evidence that IL2RG and LMO2 do cooperate in leukemia induction [134].